Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bladder Cancer Detection Using FISH (UroVysion Assay)

18 Aug 2008

Abstract excerpt

UroVysion is a fluorescence in situ hybridization assay that was developed for the detection of bladder cancer in urine specimens. It consists of fluorescently labeled DNA probes to the pericentromeric regions of chromosomes 3 (red), 7 (green), and 17 (aqua) and to the 9p21 band (gold) location of the P16 tumor suppressor gene. The UroVysion assay works by detecting urinary cells that have chromosomal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18724101
DOI: 10.1097/pap.0b013e3181832320

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bladder Cancer Detection Using FISH (UroVysion Assay)PMID 18724101Read ↗

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right CatchSemantic proximity Read ↗

Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancerSemantic proximity Read ↗

Fluorescence in situ hybridization for detecting urothelial carcinomaSemantic proximity Read ↗

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinomaSemantic proximity Read ↗

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With HematuriaSemantic proximity Read ↗

Fluorescence-in-situ-hybridization in the Surveillance of Urothelial Cancers: Can Use of Cystoscopy or Ureteroscopy be Deferred?Semantic proximity Read ↗

DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical TrialSemantic proximity Read ↗

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerSemantic proximity Read ↗

A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort StudySemantic proximity Read ↗

Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidySemantic proximity Read ↗

Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urineSemantic proximity Read ↗

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.